ChemoCentryx, Inc. (NASDAQ: CCXI) was downgraded by analysts at Canaccord Genuity Group Inc. from a "buy" rating to a "hold" rating. They now have a $52.00 price target on the stock.
ChemoCentryx, Inc. (CCXI)
Last chemocentryx, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.chemocentryx.com
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
CCXI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CCXI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CCXI alerts
High impacting ChemoCentryx, Inc. news events
Weekly update
A roundup of the hottest topics
CCXI
News
- Shareholder Alert - The M&A Class Action Firm Announces the Investigation of ChemoCentryx, Inc. - CCXIPR Newswire
- ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference CallGlobeNewswire
- SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates AAWW, CCXI, IRBTGlobeNewswire
- CHEMOCENTRYX, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of CCXI and Encourages Investors to Contact the FirmGlobeNewswire
- ChemoCentryx, Inc. (NASDAQ: CCXI) had its "market perform" rating re-affirmed by analysts at SVB Leerink LLC. They now have a $52.00 price target on the stock, down previously from $64.00.MarketBeat
CCXI
Earnings
- 8/8/22 - Beat
CCXI
Sec Filings
- 8/9/22 - Form DEFA14A
- 8/8/22 - Form 4
- 8/8/22 - Form 4
- CCXI's page on the SEC website